|
Esperion Falling Further
|
2
|
Resverlogix Corp.
|
Jul 29, 2015 02:23PM
|
|
Equity offering
|
5
|
Zenith Epigenetics
|
Jun 04, 2018 04:39PM
|
|
Edmonton Journal Article
|
10
|
Resverlogix Corp.
|
Jan 18, 2022 07:49PM
|
|
Dr Nichols still loves Esperion
|
1
|
Resverlogix Corp.
|
Oct 11, 2017 03:20PM
|
|
Dr Johann
|
7
|
Resverlogix Corp.
|
Apr 04, 2016 04:33PM
|
|
Don on CTV Calgary News 6:18pm
|
6
|
Resverlogix Corp.
|
Jan 24, 2022 08:24PM
|
|
DM Interview w Jane King (Innovators) Apr 7 - COVID 19
|
14
|
Resverlogix Corp.
|
Apr 08, 2020 08:38PM
|
|
Discount Brokerages - Zenith Valuations
|
3
|
Zenith Epigenetics
|
Jan 15, 2016 09:49AM
|
|
Discount Brokerages
|
1
|
Resverlogix Corp.
|
Dec 17, 2015 01:13PM
|
|
COVID trial now in CTD
|
10
|
Resverlogix Corp.
|
May 15, 2021 11:51AM
|
|
Competition from Constellation
|
4
|
Zenith Epigenetics
|
Dec 13, 2017 09:01AM
|
|
Coincidence
|
10
|
Resverlogix Corp.
|
Nov 11, 2015 12:04PM
|
|
Clovis' Rubracra
|
6
|
Zenith Epigenetics
|
Oct 03, 2018 01:02PM
|
|
BET Inhibitors may help Overcome a Newly Recognized Form of Resistance to Prostate Cancer Drugs
|
5
|
Zenith Epigenetics
|
Jun 22, 2021 09:34AM
|
|
Beacon report spreading
|
7
|
Resverlogix Corp.
|
Dec 07, 2017 08:06PM
|
|
Beacon reiterates assessment
|
5
|
Resverlogix Corp.
|
Dec 20, 2017 07:38PM
|
|
Awaken Dormant DNA, Epigenetically - Article in GEN
|
6
|
Zenith Epigenetics
|
Jan 12, 2018 06:03PM
|
|
Article in National Post Feb 11
|
11
|
Resverlogix Corp.
|
Feb 12, 2022 09:38AM
|
|
Another reason for Zenith to get busy with a Nasdaq listing
|
4
|
Zenith Epigenetics
|
Oct 03, 2016 12:47PM
|
|
Anne McCaffrey passing
|
17
|
Resverlogix Corp.
|
Jun 04, 2021 11:51AM
|
